Our recent investigations [98,118] revealed markedly lower ficolin-1 concentrations in patients suffering from multiple myeloma or acute myeloid leukaemia (before chemotherapy), compared with controls. This evidence concerns the gene FCN1 and acute myeloid leukemia.